Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended Decembe...(d its reversal in 2007 ...)

its reversal in 2007 282 (282)

Reverse travel costs related to

acquisitions previously capitalized

as goodwill - 380

Reclassify royalties that had been

expensed in general and administrative

(note a) - (577)

Litigation expenses related to 2006 and

its reversal in 2007 (680) 680

---------------------------

(398) 201

---------------------------

d.) Income tax expense from continuing

operations adjustments:

Tax adjustment related to finalization

of the 2007 income tax provision 5,184 -

Correction of income tax error in 2006

and its reversal in 2007 1,900 (7,298)

Reclassify income tax expense from

discontinued operations 1,502 -

Tax effect on the adjustments of a.

through c. in 2006 and its reversal

in 2007 477 (889)

------------- -------------

9,063 (8,187)

------------- -------------

e.) Net loss from discontinued operations

adjustment:

Reclassify income tax expense to

continuing operations (note d) 1,502 -

------------- -------------

'/>"/>